New research into bone metastases

Galapagos, a Belgian biotech company, started a clinical phase 1 study of
GLPG0187. This is supposed to block five receptors which are present in
bone metastases of prostate cancer.
Animal tests proved that it stops the diffusion and growth of the tumor, as
well as eliminating further bone destruction.

Visit Gemini-aquarius7.com

You will find Affiliates: Wonderlabs Labs (oral Chelation - Good Variety of
Herbs) - CloudNine ( Anti-Aging products )
You will be able to subscribe to a Satellite web site to watch TV online -
or download from (movies all free)

Also a Canadian Company called Tiger Direct ( you will find a large variety
of Products)
An other important Affiliate Gemini-Aquarius7 Amazon Store - a very
interesting Store to Visit.



"Andre" <patrouillie@hotmail.com> wrote in message
news:PJIZl.7782$mh5.4443@newsfe01.ams2...
> Galapagos, a Belgian biotech company, started a clinical phase 1 study of
> GLPG0187. This is supposed to block five receptors which are present in
> bone metastases of prostate cancer.
> Animal tests proved that it stops the diffusion and growth of the tumor,
> as well as eliminating further bone destruction.
>
>

Visit Gemini-aquarius7.com

You will find Affiliates: Wonderlabs Labs (oral Chelation - Good Variety of
Herbs) - CloudNine ( Anti-Aging products )
You will be able to subscribe to a Satellite web site to watch TV online -
or download from (movies all free)

Also a Canadian Company called Tiger Direct ( you will find a large variety
of Products)
An other important Affiliate Gemini-Aquarius7 Amazon Store - a very
interesting Store to Visit.



"Andre" <patrouillie@hotmail.com> wrote in message
news:PJIZl.7782$mh5.4443@newsfe01.ams2...
> Galapagos, a Belgian biotech company, started a clinical phase 1 study of
> GLPG0187. This is supposed to block five receptors which are present in
> bone metastases of prostate cancer.
> Animal tests proved that it stops the diffusion and growth of the tumor,
> as well as eliminating further bone destruction.
>
>